Development and Validation of a Novel Circadian Rhythm-Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma

Figure 5

Validation of the risk model in the GEO cohort. (a) Distribution of the patients in the GEO cohort based on the median risk scores in TCGA. (b) Survival status of each patient (low-risk population: left side of the dashed line; high-risk population: right side of the dashed line). (c) PCA and t-SNE plot of HCCs. (d) Kaplan–Meier curves were used to compare OS in the low- and high-risk groups. (e) Time-dependent ROC curves for HCCs.

(a)

(b)

(c)

(d)

(e)